MedCap AB Statistics
Total Valuation
MedCap AB has a market cap or net worth of SEK 9.11 billion. The enterprise value is 9.27 billion.
| Market Cap | 9.11B |
| Enterprise Value | 9.27B |
Important Dates
The next estimated earnings date is Friday, February 6, 2026.
| Earnings Date | Feb 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MedCap AB has 14.99 million shares outstanding. The number of shares has increased by 0.18% in one year.
| Current Share Class | 14.99M |
| Shares Outstanding | 14.99M |
| Shares Change (YoY) | +0.18% |
| Shares Change (QoQ) | -0.19% |
| Owned by Insiders (%) | 1.20% |
| Owned by Institutions (%) | 62.87% |
| Float | 11.84M |
Valuation Ratios
The trailing PE ratio is 46.30 and the forward PE ratio is 34.94.
| PE Ratio | 46.30 |
| Forward PE | 34.94 |
| PS Ratio | 4.57 |
| PB Ratio | 6.48 |
| P/TBV Ratio | 28.34 |
| P/FCF Ratio | 31.02 |
| P/OCF Ratio | 28.69 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 24.81, with an EV/FCF ratio of 31.55.
| EV / Earnings | 47.06 |
| EV / Sales | 4.65 |
| EV / EBITDA | 24.81 |
| EV / EBIT | 36.25 |
| EV / FCF | 31.55 |
Financial Position
The company has a current ratio of 2.34, with a Debt / Equity ratio of 0.36.
| Current Ratio | 2.34 |
| Quick Ratio | 1.63 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | 1.36 |
| Debt / FCF | 1.72 |
| Interest Coverage | 13.04 |
Financial Efficiency
Return on equity (ROE) is 15.25% and return on invested capital (ROIC) is 9.24%.
| Return on Equity (ROE) | 15.25% |
| Return on Assets (ROA) | 7.30% |
| Return on Invested Capital (ROIC) | 9.24% |
| Return on Capital Employed (ROCE) | 12.49% |
| Revenue Per Employee | 3.36M |
| Profits Per Employee | 332,601 |
| Employee Count | 592 |
| Asset Turnover | 0.91 |
| Inventory Turnover | 2.92 |
Taxes
In the past 12 months, MedCap AB has paid 58.60 million in taxes.
| Income Tax | 58.60M |
| Effective Tax Rate | 22.79% |
Stock Price Statistics
The stock price has increased by +9.95% in the last 52 weeks. The beta is 0.37, so MedCap AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.37 |
| 52-Week Price Change | +9.95% |
| 50-Day Moving Average | 592.96 |
| 200-Day Moving Average | 486.16 |
| Relative Strength Index (RSI) | 57.56 |
| Average Volume (20 Days) | 17,788 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MedCap AB had revenue of SEK 1.99 billion and earned 196.90 million in profits. Earnings per share was 13.13.
| Revenue | 1.99B |
| Gross Profit | 1.16B |
| Operating Income | 255.60M |
| Pretax Income | 257.10M |
| Net Income | 196.90M |
| EBITDA | 336.00M |
| EBIT | 255.60M |
| Earnings Per Share (EPS) | 13.13 |
Balance Sheet
The company has 358.70 million in cash and 506.10 million in debt, giving a net cash position of -147.40 million or -9.84 per share.
| Cash & Cash Equivalents | 358.70M |
| Total Debt | 506.10M |
| Net Cash | -147.40M |
| Net Cash Per Share | -9.84 |
| Equity (Book Value) | 1.41B |
| Book Value Per Share | 93.39 |
| Working Capital | 580.80M |
Cash Flow
In the last 12 months, operating cash flow was 317.60 million and capital expenditures -23.90 million, giving a free cash flow of 293.70 million.
| Operating Cash Flow | 317.60M |
| Capital Expenditures | -23.90M |
| Free Cash Flow | 293.70M |
| FCF Per Share | 19.60 |
Margins
Gross margin is 58.08%, with operating and profit margins of 12.83% and 9.89%.
| Gross Margin | 58.08% |
| Operating Margin | 12.83% |
| Pretax Margin | 12.91% |
| Profit Margin | 9.89% |
| EBITDA Margin | 16.87% |
| EBIT Margin | 12.83% |
| FCF Margin | 14.75% |
Dividends & Yields
MedCap AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.18% |
| Shareholder Yield | -0.18% |
| Earnings Yield | 2.16% |
| FCF Yield | 3.22% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 27, 2016. It was a reverse split with a ratio of 0.1.
| Last Split Date | Sep 27, 2016 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |